Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Rifampin drug resistance tests for tuberculosis: challenging the gold standard.

Van Deun A, Aung KJ, Bola V, Lebeke R, Hossain MA, de Rijk WB, Rigouts L, Gumusboga A, Torrea G, de Jong BC.

J Clin Microbiol. 2013 Aug;51(8):2633-40. doi: 10.1128/JCM.00553-13. Epub 2013 Jun 12.

2.

Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in rural Bangladesh: lessons learnt.

Gumusboga A, Aung KJ, Rigouts L, Van Deun A.

Public Health Action. 2012 Sep 21;2(3):76-8. doi: 10.5588/pha.12.0015.

3.

Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout.

Aung KJ, Declercq E, Ali MA, Naha S, Datta Roy SC, Taleb MA, Hossain MA, Rigouts L, Gumusboga A, Van Deun A.

Int J Tuberc Lung Dis. 2012 Apr;16(4):455-61. doi: 10.5588/ijtld.11.0216.

PMID:
22640511
4.

Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE.

Antimicrob Agents Chemother. 2009 Mar;53(3):1061-6. doi: 10.1128/AAC.01357-08. Epub 2008 Dec 22.

5.

Measurement of Rab5 protein kinase B/akt and regulation of ras-activated endocytosis.

Barbieri MA, Gumusboga A, Roberts RL, Stahl PD.

Methods Enzymol. 2001;329:145-56. No abstract available.

PMID:
11210531
6.

Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.

Barbieri MA, Roberts RL, Gumusboga A, Highfield H, Alvarez-Dominguez C, Wells A, Stahl PD.

J Cell Biol. 2000 Oct 30;151(3):539-50.

7.

Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase.

Shyng SL, Barbieri A, Gumusboga A, Cukras C, Pike L, Davis JN, Stahl PD, Nichols CG.

Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):937-41.

Supplemental Content

Loading ...
Support Center